EUVIMEDEUVIMED entdecken
Open Access

Lipomatous Metaplasia Is Associated With Ventricular Tachycardia Recurrence Following Ablation in Patients With Nonischemic Cardiomyopathy

Lingyu Xu, Mirmilad Khoshknab, Juwann Moss, Ronald D Berger, Jonathan Chrispin, David Callans, Francis E Marchlinski, Stefan L Zimmerman, Yuchi Han, Natalia Trayanova, Benoit Desjardins, Saman Nazarian

JACC: Clinical Electrophysiology · 2024-06 · 10 (6) · 1135-1146

DOI: 10.1016/j.jacep.2024.02.024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2024-06. Verfasst von Lingyu Xu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Medicine Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Tachycardia, Ventricular, Cardiomyopathies, Catheter Ablation, Recurrence. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Ventricular tachycardia (VT) recurrence rates remain high following ablation among patients with nonischemic cardiomyopathy (NICM). OBJECTIVES: This study sought to define the prevalence of lipomatous metaplasia (LM) in patients with NICM and VT and its association with postablation VT recurrence. METHODS: From patients who had ablation of left ventricular VT, we retrospectively identified 113 consecutive NICM patients with preprocedural contrast-enhanced cardiac computed tomography (CECT), from which LM was segmented. Nested within this cohort were 62 patients that prospectively underwent CECT and cardiac magnetic resonance from which myocardial border zone and dense late gadolinium enhancement (LGE) were segmented. A control arm of 30 NICM patients without VT with CECT was identified. RESULTS: LM was identified among 57% of control patients without VT vs 83% of patients without VT recurrence and 100% of patients with VT recurrence following ablation. In multivariable analyses, LM extent was the only independent predictor of VT recurrence, with an adjusted HR per 1-g LM increase of 1.1 (P < 0.001). Patients with LM extent ≥2.5 g had 4.9-fold higher hazard of VT recurrence than those with LM

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tachycardia, VentricularCardiomyopathiesCatheter AblationRecurrenceMetaplasiaHumansMaleFemaleMiddle AgedAgedRetrospective StudiesMagnetic Resonance ImagingTomography, X-Ray ComputedLipomatosis

Stichwörter der Autor:innen

lipomatous metaplasianonischemic cardiomyopathyventricular tachycardia

Autor:innen und Institutionen

  • Cardiovascular Medicine Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA; Department of Cardiology, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Radiology and Radiological Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland, USA.
  • Department of Radiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA.
  • Cardiovascular Medicine Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. Electronic address: saman.nazarian@pennmedicine.upenn.edu.

Förderung

  • NHLBI NIH HHS
  • NIH

Zitieren

APA

Xu, L., Khoshknab, M., Moss, J., Berger, R. D., Chrispin, J., Callans, D., Marchlinski, F. E., Zimmerman, S. L., Han, Y., Trayanova, N., Desjardins, B., & Nazarian, S. (2024). Lipomatous Metaplasia Is Associated With Ventricular Tachycardia Recurrence Following Ablation in Patients With Nonischemic Cardiomyopathy. JACC: Clinical Electrophysiology, 10(6), 1135-1146. https://doi.org/10.1016/j.jacep.2024.02.024

Vancouver

Xu L, Khoshknab M, Moss J, Berger RD, Chrispin J, Callans D, et al. Lipomatous Metaplasia Is Associated With Ventricular Tachycardia Recurrence Following Ablation in Patients With Nonischemic Cardiomyopathy. JACC: Clinical Electrophysiology. 2024;10(6):1135-1146. doi:10.1016/j.jacep.2024.02.024

BibTeX
@article{Xu2024,
  author = {Xu, Lingyu and Khoshknab, Mirmilad and Moss, Juwann and Berger, Ronald D and Chrispin, Jonathan and Callans, David and Marchlinski, Francis E and Zimmerman, Stefan L and Han, Yuchi and Trayanova, Natalia and Desjardins, Benoit and Nazarian, Saman},
  title = {Lipomatous Metaplasia Is Associated With Ventricular Tachycardia Recurrence Following Ablation in Patients With Nonischemic Cardiomyopathy},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  volume = {10},
  number = {6},
  pages = {1135--1146},
  doi = {10.1016/j.jacep.2024.02.024}
}
Kostenlos starten →